A kinome-wide selective radiolabeled TrkB/C inhibitor for in vitro and in vivo neuroimaging: synthesis, preclinical evaluation, and first-in-human

The proto-oncogenes NTRK1/2/3 encode the tropomyosin receptor kinases TrkA/B/C which play pivotal roles in neurobiology and cancer. We describe herein the discovery of [11C]-(R)-3 ([11C]-(R)-IPMICF16), a first-in-class positron emission tomography (PET) TrkB/C-targeting radiolabeled kinase inhibitor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bernard-Gauthier, Vadim (VerfasserIn) , Mahringer, Anne (VerfasserIn) , Fricker, Gert (VerfasserIn) , Wängler, Björn (VerfasserIn)
Weitere Verfasser: soucy, jean-paul (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017
In: Journal of medicinal chemistry
Year: 2017, Jahrgang: 60, Heft: 16, Pages: 6897-6910
ISSN:1520-4804
DOI:10.1021/acs.jmedchem.7b00396
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1021/acs.jmedchem.7b00396
Verlag, Volltext: https://doi.org/10.1021/acs.jmedchem.7b00396
Volltext
Verfasserangaben:Vadim Bernard-Gauthier, Justin J. Bailey, Andrew V. Mossine, Simon Lindner, Lena Vomacka, Arturo Aliaga, Xia Shao, Carole A. Quesada, Phillip Sherman, Anne Mahringer, Alexey Kostikov, Marilyn Grand’Maison, Pedro Rosa-Neto, Jean-Paul Soucy, Alexander Thiel, David R. Kaplan, Gert Fricker, Björn Wängler, Peter Bartenstein, Ralf Schirrmacher, and Peter J.H. Scott
Beschreibung
Zusammenfassung:The proto-oncogenes NTRK1/2/3 encode the tropomyosin receptor kinases TrkA/B/C which play pivotal roles in neurobiology and cancer. We describe herein the discovery of [11C]-(R)-3 ([11C]-(R)-IPMICF16), a first-in-class positron emission tomography (PET) TrkB/C-targeting radiolabeled kinase inhibitor lead. Relying on extensive human kinome vetting, we show that (R)-3 is the most potent and most selective TrkB/C inhibitor characterized to date. It is demonstrated that [11C]-(R)-3 readily crosses the blood-brain barrier (BBB) in rodents and selectively binds to TrkB/C receptors in vivo, as evidenced by entrectinib blocking studies. Substantial TrkB/C-specific binding in human brain tissue is observed in vitro, with specific reduction in the hippocampus of Alzheimer’s disease (AD) versus healthy brains. We additionally provide preliminary translational data regarding the brain disposition of [11C]-(R)-3 in primates including first-in-human assessment. These results illustrate for the first time the use of a kinome-wide selective radioactive chemical probe for endogenous kinase PET neuroimaging in human.
Beschreibung:Publication Date (Web): July 11, 2017
Gesehen am 28.06.2018
Beschreibung:Online Resource
ISSN:1520-4804
DOI:10.1021/acs.jmedchem.7b00396